Pharma Integrates 2021 Agenda

Session 1:

09:50- 10:40

Home & away

Has remote working changed the culture in pharma? What will future working environments and practices look like?

Session 2:

10:50- 11:40

I’ve got skills, they’re multiplying

With the ambitious UK Life Science Strategy and the Brexit brain drain, how can we ensure we have the skills in place to deliver future products for patients?

Networking

11:40-12:00

Session 3:

12:05- 12:55

Howdy partner!

Collaboration has been imperative in delivering the next generation of medicines. How will traditional and non-traditional partnerships deliver the best therapeutics for patients?

Session 4:

13:05 – 13:55

Mental Health in the Workplace

Millennials, Zoomer and Boomers – Mental Health affects us all: supporting our people during and after the pandemic?

Networking

13:55 – 14:15

Session 5

14:20 – 15:10

Waiting patiently

The pandemic has made patients much more aware, and in some cases sceptical, of medicines development. How can we engage, educate and empower patients to enable medicines to reach them more quickly?

Session 6:

15:20 – 16:10

Preventing the next pandemics

As we approach the end of 2021, the prevention agenda has become more relevant than ever.
Has the pandemic set public health back? Can we do better? Better risk prediction, better prevention interventions, better distribution of funding and use of technologies to solve the problems we are facing?
How can we think creatively to reimagine public health and what will we be saying about progress in 10 years’ time?

Closing Remarks

16:20- 16:30

TREVOR JONES CBE | Chairman and Board Member | e-Therapeutics, Respiratory Innovation Wales and Ascension Healthcare

PROCESSES

How can we adapt our processes to accelerate the development and delivery of medicines?

Session 1:

09:50 – 10:40

I feel the need for speed

Coronavirus vaccines were developed at unprecedented speed. With growing expectations that drugs are made more quickly, how can we accelerate timelines?

Session 2:

10:50 – 11:40

Underpinning the Future of Healthcare with High Performance Computing and Artificial Intelligence.

The need for a faster, more fluid research environment is driving the adoption of advanced computing technologies

Networking

11:40 – 12:00

Session 3:

12:05 – 12:55

Are you in or out?

While pharma outsourcing is still on the rise, the pandemic has led to near-shoring or activities being brought in-house to ensure milestones could be met. Where will we make our medicines in the future?

Session 4:

13:05 – 13:55

Genomics is Key

The past decade has seen genetically targeted therapies go from theory to practice, particularly in the field of oncology. Every new disease-causing gene discovered opens up a new line of attack on rare, intractable, and chronic diseases, but health systems risk multiple bottlenecks that might derail progress. While there are ethical, logistical, and scientific challenges to overcome, what might the potential opportunity be for genetically characterised populations to accelerate research and care?

Session 5:

15:20 – 16:10

Pharma on trial

Time is always of the essence for clinical programmes. How do we design for stratification, speed and ultimately success, and how do we make the most of clinical data?

Closing Remarks

16:20- 16:30

TREVOR JONES CBE | Chairman and Board Member | e-Therapeutics, Respiratory Innovation Wales and Ascension Healthcare

PREDICTIONS

How can we predict future pharma needs and prevent the next pandemics? How can we use the current focus on pharma to demystify medicines?

Session 1:

09:50 – 10:40

Delivering on the promise of net zero: beyond commitments

This fireside chat brings together stakeholders from government, healthcare systems, professionals, pharmaceutical and medical technology companies to reflect on the success to date in the sector (with achieving Race to Zero Breakthrough Ambition), and beyond commitments, what is needed next to drive action towards these goals and net zero by 2050.

Session 2:

10:50 – 11:40

Active Collaboration with Your Excipient Supplier Could Optimise Formulation Development

It takes a village to raise a child, it takes a whole pharmaceutical ecosystem to launch a new drug

Networking

11:40 – 12:00

Session 3:

12:05 – 12:55

In the spotlight

Previously the pharma industry has not been the most popular. Now all eyes are on us. How can we use this focus to demystify medicines and convey our impact?

Session 4:

13:05 – 13:55

Fast Forward – The future of Pharma Supply Chains

• What could/should supply chains look like 10 years from now?
• Responding to the shift towards patient-centric and personalised medicine
• What the pandemic taught us about how quickly we can build supply chains (when we have to)
• Innovation and emerging technology trends……what tech can be deployed today and what will be needed in the future?

Networking

13:55 – 14:15

Session 6:

15:20 – 16:10

Forecasting Pharma’s future

When the pandemic is finally behind us, what will the future of health look like?

Closing Remarks

16:20- 16:30

TREVOR JONES CBE | Chairman and Board Member | e-Therapeutics, Respiratory Innovation Wales and Ascension Healthcare